Growth Metrics

Insulet (PODD) Total Debt Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 157.11%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -12.26%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 5.50%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -2.48%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.12%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 8.70%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 15.70%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -5.48%
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn -44.08%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -44.08%
Dec 31, 2025 -31.21%
Sep 30, 2025 -27.43%
Jun 30, 2025 0.14%
Mar 31, 2025 20.97%
Dec 31, 2024 -2.54%
Sep 30, 2024 -1.56%
Jun 30, 2024 0.00%
Mar 31, 2024 0.35%
Dec 31, 2023 1.00%
Sep 30, 2023 0.97%
Jun 30, 2023 -0.97%
Mar 31, 2023 -1.38%
Dec 31, 2022 10.04%
Sep 30, 2022 9.39%
Jun 30, 2022 12.37%
Mar 31, 2022 32.69%
Dec 31, 2021 20.26%
Sep 30, 2021 39.54%
Jun 30, 2021 38.00%
Mar 31, 2021 18.72%
Dec 31, 2020 19.30%
Sep 30, 2020 -6.52%
Jun 30, 2020 49.86%
Mar 31, 2020 49.93%
Dec 31, 2019 49.98%
Sep 30, 2019 68.66%
Jun 30, 2019 5.24%
Mar 31, 2019 5.22%
Dec 31, 2018 4.56%
Sep 30, 2018 69.44%
Jun 30, 2018 69.32%
Mar 31, 2018 69.22%
Dec 31, 2017 70.14%
Sep 30, 2017 4.86%
Jun 30, 2017 94.00%
Mar 31, 2017 93.90%
Dec 31, 2016 93.81%
Sep 30, 2016 89.20%
Jun 30, 2016 2.01%
Mar 31, 2016 1.81%
Dec 31, 2015 4.68%
Sep 30, 2015 3.85%
Jun 30, 2015 -9.24%
Mar 31, 2015 46.71%
Dec 31, 2014 44.32%
Sep 30, 2014 50.67%
Jun 30, 2014 74.61%
Mar 31, 2014 -3.84%
Dec 31, 2013 -3.82%
Sep 30, 2013 -3.92%
Jun 30, 2013 -4.03%
Mar 31, 2013 9.09%
Dec 31, 2012 8.86%
Dec 31, 2011 56.32%